REGENXBIO
Business Services · Maryland, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
9804 Medical Center Dr, Rockville, Maryl...Phone Number
(240) 552-8181Website
www.regenxbio.comRevenue
$174.5 MillionStock Symbol
RGNXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
3
1
1
2
2
1
About REGENXBIO
REGENXBIO Inc. is a clinical-stage biotechnology company. It specializes in providing gene therapy product. The company was founded in 2008 and is headquartered in Rockville, Maryland.Explore more
REGENXBIO Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is REGENXBIO your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
REGENXBIO, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on REGENXBIO recently announced quarterly report
Click to see if REGENXBIO had a recent Job posting/layoffs
Check out if REGENXBIO is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at REGENXBIO
Check if REGENXBIO has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once REGENXBIO has new funding data
Product Launch: Get notified when REGENXBIO launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to REGENXBIO
Compare insights from companies similar to REGENXBIO, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
REGENXBIO is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
REGENXBIO is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about REGENXBIO.
REGENXBIO financials insights
Gather financial insights about REGENXBIO, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$138.6M
REGENXBIO Tech Stack
A closer look at the technologies used by REGENXBIO
See more technologies
Most Recent Scoops
Open Position
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Intellectual Property, Legal Affairs
Earnings
Earnings, Finance
Earnings
Earnings, Finance
REGENXBIO News & Media
REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli
ROCKVILLE, Md., Aug. 25, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced the appointment of Greg Ciongoli to its Board of Directors, effective August 25, 2026. With multiple upcoming catalysts across its late-stage pipeline of potential first-and best-in-class gene...FDA places clinical hold on REGENXBIO’s RGX-121 in MPS II trial
The update follows the detection of asymptomatic findings in the spine MRIs of five participants enrolled in the CAMPSIITE study.RGNX Investor Notice: Johnson Fistel Investigates REGENXBIO Inc. Following Clinical Hold
SAN DIEGO, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating REGENXBIO Inc. (NASDAQ: RGNX) on behalf of investors who suffered losses and whether those losses may be recoverable under federal securities laws. If you purchased REGENXBIO securities and suffered losses, click here to join the investigation.REGENXBIO Announces Regulatory Update on RGX-121 for MPS II
ROCKVILLE, Md., Aug. 24, 2026 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today provided an update on its investigational gene therapy, RGX-121 (clemidsogene lanparvovec), for the treatment of Mucopolysaccharidosis type II (MPS II), also known as Hunter Syndrome. The U.S. Food and Drug...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding REGENXBIO
Sign Up For FreeTo access detailed company insights
REGENXBIO Inc. is a clinical-stage biotechnology company. It specializes in providing gene therapy product. The company was founded in 2008 and is headquartered in Rockville, Maryland.... Read More
